Validation of fully automated intensity-modulated proton therapy with and without transmission beams for nasopharyngeal cancer

全自动调强质子治疗(有/无透射束)治疗鼻咽癌的验证

阅读:1

Abstract

BACKGROUND AND PURPOSE: Intensity-modulated proton therapy (IMPT) offers dose/volume advantages for nasopharyngeal cancer (NPC), however is complex, time-consuming, and the Bragg-peak's broad lateral penumbra can compromise target coverage near critical structures. Transmission proton beams (TBs) may mitigate this, while fully automated planning can ensure high-quality plans with reduced planning times. This study aimed to evaluate the added value of TBs in robust, fully automated IMPT (autoIMPT) planning for NPC, and benchmarking these against manually generated clinical IMPT plans. MATERIALS AND METHODS: Twenty-four NPC patients previously treated with IMPT with 70.00 Gy(RBE) to the primary tumor and 54.25 Gy(RBE) to the elective volumes were included. AutoIMPT- and autoIMPT+TB plans were generated by Erasmus-iCycle, using the same 6-beam configuration and clinical constraints. Dose/volume-based comparison to clinical plans was performed for target coverage, OAR doses, and normal tissue complication probabilities (NTCP). RESULTS: Voxel-wise (vw) minimum target D98% of automated plans was similar or improved compared to clinical plans, especially in cases with compromised target coverage. In serial OARs, significant dose reductions were observed, especially in brainstem and optical system. Dose reductions to serial OARs were more pronounced in the autoIMPT+TB plans, up to 22.5 Gy for vw-maximum optical nerve D0.03cm(3). Similarly, dose reductions in most parallel OARs were observed (-13.2 Gy in pituitary Dmean). NTCP for dysphagia remained equal; xerostomia NTCP was significantly lower in the automated plans. CONCLUSIONS: Fully automated IMPT and IMPT+TB plans achieved similar or improved robust target coverage and OAR sparing compared to clinical plans. Incorporation of TBs to IMPT showed similar target coverage and enhanced dose reductions in serial OARs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。